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1 Introduction
A central statistical problem in precision medicine and health policy is to learn treatment rules that
are tailored to the patient’s characteristics. There is now an exploding literature on individualized
policy discovery; see Kosorok and Laber [2019] for an up-to-date review. Although randomized
experiments remain the gold standard for causal inference, there has been a growing interest in
using observational data to draw causal conclusions and discover individualized treatment rules
due to the increasing availability of electronic health records and other observational data sources
[Moodie et al., 2012, Athey and Wager, 2017, Kallus, 2017, Wu et al., 2019, Zhao et al., 2019b].
A common way to formulate the problem of individualized policy discovery is via the value
function, which is the expected potential outcome under a treatment rule or regime. The optimal
treatment rule is usually defined as the one that maximizes the value function. In the single-
decision setting, the value function can be easily identified when the data come from a randomized
experiment (as long as the probability of receiving treatment is never 0 or 1). When the data
come from an observational study, the value function can still be identified under the assumption
that all confounders are measured. This assumption can be further extended to the multiple-
decision setting [Murphy, 2003, Robins, 2004]. In this paper we will focus our discussion on the
single-decision setting but consider the possibility of unmeasured confounding.
With few exceptions, the vast majority of existing methods for treatment rule discovery from
observational data are based on the no unmeasured confounding assumption. Typically, these
methods first estimate the value function assuming no unmeasured confounding and then select
the treatment rule that maximizes the estimated value function. However, it is common that a
substantial fraction of the population appear to behave similarly under treatment or control. From
a statistical perspective and if there is truly no unmeasured confounder, we should still attempt to
estimate the treatment effect for individuals in this subpopulation and optimize the treatment rule
accordingly. However, the optimal treatment decisions for these individuals are, intuitively, also
the most sensitive to unmeasured confounding. It may only take a small amount of unmeasured
confounding to change the sign of the estimated treatment effects for these individuals. From a
policy perspective (especially when there is a cost constraint), learning the “optimal” treatment
decision for these individuals from observational data seems likely to be error-prone.
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1.1 Sensitivity analysis for individualized treatment rules
There is a long literature on studying the sensitivity of observational studies to unmeasured con-
founding, dating from Cornfield et al. [1959]. In short, such sensitivity analysis asks how much
unmeasured confounding is needed to alter the causal conclusion of an observational study qualita-
tively. In this paper, we will study the sensitivity of individualized treatment rules to unmeasured
confounding using a prominent model proposed by Rosenbaum [1987], where the odds ratio of
receiving the treatment for any two individuals with the same observed covariates is bounded be-
tween 1/Γ and Γ (Γ ≥ 1; Γ = 1 corresponds to no unmeasured confounding). More specifically,
we will consider selecting and ranking individualized treatment rules under Rosenbaum’s model for
unmeasured confounding.
Our investigation is motivated by the impact of effect modification on the power of Rosenbaum’s
sensitivity analysis that is studied by Hsu et al. [2013]. A phenomenon found by Hsu et al. [2013]
is that subgroups with larger treatment effect may have larger design sensitivity. For example,
suppose a subgroup A has larger treatment effect than a subgroup B based on observational data.
Then, there may exist a Γ > 1 such that, when the sample size of both subgroups go to infinity, the
probability of rejecting Fisher’s sharp null hypothesis under the Γ-sensitivity model goes to 1 for
subgroup A and 0 for subgroup B. Therefore, to obtain causal conclusions that are most robust to
unmeasured confounding, it may be more desirable to use a smaller subgroup with larger treatment
effect than to use a larger subgroup with smaller treatment effect.
When comparing individualized treatment rules to a baseline, the above phenomenon suggests
that a treatment rule with smaller value may be less sensitive to unmeasured confounding than
a treatment rule with larger value. In other words, when there is unmeasured confounding, the
“optimal” treatment rule might not be the one that maximizes the value function assuming no
measured confounding; in fact, there are usually many “optimal” treatment rules. This is because
the value function in this case only defines a partial order on the set of individualized treatment
rules, so two rules with different value function assuming no unmeasured confounding may become
indistinguishable under the Γ-sensitivity model when Γ > 1. Fundamentally, the reason is that the
value function is only partially identified in Rosenbaum’s Γ-sensitivity model.
As an example, let’s use r2 Γ r1 (abbreviated as r2  r1 if the value of Γ is clear from
the context) to denote that the value of rule r2 is always greater than the value of r1 when the
unmeasured confounding satisfies the Γ-sensitivity model. Then, it is possible that
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• Under Γ = 1, r2  r1  r0 (so r2  r0);
• Under some Γ > 1, r1  r0 but r2 6 r0.
This phenomenon occurs frequently in real data examples, see Figure 1 in Section 3.2. Note that the
relation  is defined using the value function computed using the population instead of a particular
sample.
Because the value function only defines a partial order on the treatment rules, it is no longer well-
defined to estimate the optimal treatment rule when there is unmeasured confounding. Instead, we
aim to recover the partial ordering of a set of treatment rules or select a subset of rules that satisfy
certain statistical properties. This problem is related to the problem of selecting and ranking
subpopulations (as a post hoc analysis for randomized experiments) which has been extensively
studied in statistics [Gupta and Panchapakesan, 1979, Gibbons et al., 1999]. Unfortunately, in
problems considered by the existing literature, the subpopulations always have a total order. For
example, a prototypical problem in that literature is to select a subset that contains the largest µi
based on independent observations Yi ∼ N(µi, 1). It is evident that the methods developed there
cannot be directly applied to the problem of comparing treatment rules which only bears a partial
order. Nevertheless, we will borrow some definitions in that literature to define the goal of selecting
and ranking individualized treatment rules.
1.2 Related work and our approach
Existing methods for individualized policy discovery from observational data often take an ex-
ploratory stance. They often aim to select the individualized treatment rule, often within an
infinite-dimension function class, that maximized the estimated value function using outcome
regression-based [Robins, 2004, Qian and Murphy, 2011], inverse-probability weighting [Zhao et al.,
2012, Kallus, 2017], or doubly-robust estimation[Dud´ık et al., 2014, Athey and Wager, 2017]. In
order to estimate the value function, some parametric or semiparametric models are specified to
model the outcome and/or the treatment selection process. To identify the value function, the
vast majority of these approaches make the no unmeasured confounding assumption which may be
unrealistic in many applications. The only exception to our knowledge is Kallus and Zhou [2018],
in which the authors propose to maximize the minimum value of an individualized treatment rule
when the unmeasured confounding satisfies a marginal sensitivity model [Tan, 2006, Zhao et al.,
2019a]. This is further extended to the estimation of conditional average treatment effect with
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unmeasured confounding in Kallus et al. [2018]. Another related work is Yadlowsky et al. [2018]
who consider semiparametric inference for the average treatment effect in Rosenbaum’s sensitivity
model.
In this paper we take a different perspective. Our approach is based on a statistical test to
compare the value of two individualized treatment rules when there is limited unmeasured con-
founding. Briefly speaking, we first match the treated and control observations by the observed
covariates and then propose to use Rosenbaum’s sensitivity model to quantify the magnitude of
unmeasured confounding after matching (the deviation of the matched observational study from a
pairwise randomized experiment). At the core of our proposal is a randomization test introduced
by Fogarty [2016] to compare the value of two individualized treatment rules in Rosenbaum’ sen-
sitivity model. Based on this test, we introduce a framework to rank and select treatment rules
within a given finite collection and show that different statistical errors can be controlled with the
appropriate multiple hypothesis testing methods.
In principle, our framework can be used with an arbitrary (finite) number of pre-specified treat-
ment rules. In practice, it is more suitable for small-scale policy discovery with relatively few
decision variables, where it is not needed to use machine learning methods to discover complex
patterns or such methods have already been employed in a preliminary study to suggest a few can-
didat rules. The design-based nature of our approach makes it particularly useful for confirmatory
analyses, the importance of which is widely acknowledged in the policy discovery literature [e.g.
Kallus, 2017, Zhang et al., 2018, Kosorok and Laber, 2019]. Methods proposed in this paper thus
complement the existing literature on individualized treatment rules by providing a way to con-
firm the effectiveness of a treatment rule learned from observational data and assess its robustness
to unmeasured confounding. When there are several competing treatment rules, our framework
further facilitates the decision maker to select or rank the treatment rules using flexible criteria.
The rest of the paper is organized as follows. In Section 2 we introduce a real data example that
will be used to illustrate the proposed methods. We then introduce some notations and discuss how
to compare two treatment rules when there is unmeasured confounding. In Section 3 we consider
three questions about ranking and selecting among multiple treatment rules. We compare our
proposal with some baseline procedures in a simulation study Section 4 and apply our method to
another application using data from the Health and Retirement Study. Finally, we conclude our
paper with some brief discussion in Section 6.
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2 Comparing treatment rules with unmeasured confounding
2.1 Running example: Malaria in West Africa
The Garki Project, conducted by the World Health Organization and the Government of Nigeria
from 1969-1976, was an observational study that compared several strategies to control malaria. Hsu
et al. [2013] studied the effect modification for one of the malaria control strategies, namely spraying
with an insecticide, propoxur, together with mass administration of a drug sulfalene-pyrimethamine
at high frequency. The outcome is the difference between the frequency of Plasmodium falciparum
in blood samples, that is, the frequency of a protozoan parasite that causes malaria, measured
before and after the treatment. Using 1560 pairs of treated and control individuals matched by
their age and gender, Hsu et al. [2013] found that the treatment was much more beneficial for young
children than for other individuals, if there is not unmeasured confounding.
More interestingly, they found that, despite the reduced sample size, the 447 pairs of young
children exhibit a treatment effect that is far less sensitive to unmeasured confounding bias than
the full sample of 1560 pairs. So from a policy perspective, it may be preferable to implement
the treatment only for young children rather than the whole population. In the rest of this paper
we will generalize this idea to selecting and ranking treatment rules. We will use the matched
dataset in Hsu et al. [2013] to illustrate the definitions and methodologies in the paper; see the
original article for more information about the Garki Project dataset and the matched design. A
different application concerning the effect of late retirement on health outcomes will be presented
in Section 5 near the end of this article.
2.2 Some notations and definitions
We first introduce some notations in order to compare treatment rules when there is unmeasured
confounding. Let X denote all the pre-treatment covariates measured by the investigator. In
the single-decision setting considered in this paper, an individualized treatment rule (or treatment
regime) d maps a vector of pre-treatment covariates X to the binary treatment decisions, {0, 1}
(0 indicates control and 1 indicates treatment). In our running example, we shall consider six
treatment rules, r0, r1, · · · , r5, where ri assigns treatment to the youngest i×20% of the individuals.
Specifically, the minimum, 20%, 40%, 60%, 80% quantiles, and maximum of age are 0 (newborn), 7,
20, 31, 41, and 73 years old.
Let Y be the outcome and Y (0), Y (1) be the potential outcomes under control and treatment.
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The potential outcome under a treatment rule d is defined, naturally, as Y (d) = Y (0)1{d(X)=0} +
Y (1)1{d(X)=1}. A common way to compare treatment rule is to use its value function, defined
as the expected potential outcome under that rule, V (d) = E[Y (d)]. The value difference of two
treatment rules, r1 and r2, is thus
V (r2)− V (r1) = E[Y (r2)− Y (r1) | r2 6= r1] · P(r2 6= r1)
= E[Y (1)− Y (0) | r2 > r1] · P(r2 > r1)− E[Y (1)− Y (0) | r2 < r1] · P(r2 < r1),
(1)
where for simplicity the event r1(X) 6= r2(X) is abbreviated as r1 6= r2 (similarly for r1 < r2 and
r1 > r2). Note that the event r2 > r1 is the same as r2 = 1, r1 = 0 because the treatment decision
is binary. One of the terms on the right hand side of (1) will become 0 if the treatment rules are
nested. In the malaria example, r0 ≤ r1 ≤ · · · ≤ r5, so the value difference of the rules r1 and r2
can be written as
V (r2)− V (r1) = E[Y (1)− Y (0) |Age ∈ [7, 20)] · P(Age ∈ [7, 20)).
In this case, testing the sign of V (r2) − V (r1) is equivalent to testing the sign of the conditional
average treatment effect, E[Y (1)− Y (0) | r2 > r1].
The definition of the value function depends on the potential outcomes. To identify the value
function using observational data, it is standard to make the following assumptions [Kosorok and
Laber, 2019]:
1. Positivity: P(A = a |X = x) > 0 for all a and x;
2. Consistency (SUTVA): Y = Y (A);
3. Ignorability (no unmeasured confounding): Y (a) |= A |X for all a.
Under these conditions, it is straightforward to show that the value function is identified by [Qian
and Murphy, 2011]
V (d) = E
[
Y I(A = d(X))
pi(A,X)
]
,
where I is the indicator function of an event and pi(a, x) = P(A = a|X = x) is the propensity score.
The value function gives a natural and total order to the treatment rules. If the above identifica-
tion assumptions hold, the value functions can be identified and thus this order can be consistently
estimated as the sample size increases to infinity. In general, it is impossible to recover this order
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when there is unmeasured confounding. However, if the magnitude of unmeasured confounding is
bounded according to a sensitivity model (a collection of distributions of the observed variables
and unobserved potential outcomes), it is possible to partially identify difference between the value
of two treatment rules and thus obtain a partial order.
Definition 1. Let r1 and r2 be two treatment rules that map a vector of pre-treatment covariates
X to a binary treatment decision {0, 1}, and V (r1), V (r2) their corresponding value functions.
Given a sensitivity analysis model indexed by Γ, we say that the rule r1 is dominated by r2 with
a margin δ if V (r2) − V (r1) > δ for all distributions in the sensitivity analysis model. We denote
this relation as r1 ≺Γ,δ r2 and furthere abbreviate it as r1 ≺Γ r2 if δ = 0. We denote r1 6≺Γ r2 if r1
is not dominated by r2 with margin δ = 0.
Notice that the partial order should be defined in terms of the partially identified interval for
V (r2) − V (r1) instead of the partially identified intervals for V (r1) and V (r2). This is because
the same distribution of the unobserved potential outcomes needs to be used when computing the
partially identified interval for V (r2)−V (r1), so it is not simply the difference between the partially
identified intervals for the individual values (the easiest way to see this is to take r1 = r2). We
thank an anonymous reviewer for pointing this out.
It is easy to see that ≺Γ is a strict partial order on the set of treatment rules because it satisfies
irreflexivity (not r1 ≺Γ r1), transitivity (r1 ≺Γ r2 and r2 ≺Γ r3 imply r1 ≺Γ r3), and asymmetry
(r1 ≺Γ r2 implies not r2 ≺Γ r1). In Rosenbaum’s sensitivity model be introduced in the section
below, Γ = 1 corresponds to no unmeasured confounding and thus the relationship ≺Γ=1 is a total
order.
2.3 Testing r1 6≺Γ r2 using matched observational studies
With the goal of selecting and ranking treatment rules with unmeasured confounding in mind, in
this section we consider the easier but essential task of comparing the value of two treatment rules,
r1 and r2, under Rosenbaum’s sensitivity model. This test will then serve as the basic element
of our procedures of selecting and ranking among multiple treatment rules below. We will first
introduce the pair-matched design of an observational study and Rosenbaum’s sensitivity model,
and then describe a studentized sensitivity analysis proposed by Fogarty [2016] that tests Neyman’s
null hypothesis of average treatment effect being zero under Rosenbaum’s sensitivity model. This
test can be immediately extended to compare the value of treatment rules.
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Suppose the observed data are n pairs, i = 1, 2, ..., n, of two subjects j = 1, 2. These n pairs are
matched for observed covariates X and within each pair, one subject is treated, denoted Aij = 1,
and the other control, denoted Aij = 0, so that we have Xi1 = Xi2 and Ai1 + Ai2 = 1 for all i.
In a sensitivity analysis, we may fail to match on an unobserved confounder Uij and thus incur
unmeasured confounding bias.
Rosenbaum [1987, 2002] proposed a one-parameter sensitivity model. Let F = {(Yij(0), Yij(1),
Xij , Uij), i = 1, . . . , n, j = 1, 2} be the collection of all measured or unmeasured variables other
than the treatment assignment. Rosenbaum’s sensitivity model assumes that pii = P (Ai1 = 1|F)
satisfies
1
1 + Γ
≤ pii ≤ Γ
1 + Γ
, i = 1, 2, ..., n. (2)
When Γ = 1, this model asserts that pii = 1/2 for all i and thus every subject has equal probability to
be assigned to treatment or control (i.e. no unmeasured confounding). In general, Γ > 1 controls the
degree of departure from randomization. Rosenbaum [2002, 2011] derived randomization inference
based on signed score tests for Fisher’s sharp null hypothesis that Yij(0) = Yij(1) for all i, j. The
asymptotic properties of these randomization tests are studied in Rosenbaum [2004, 2015] and Zhao
[2018].
In the context of comparing individualized treatment rules, Fisher’s sharp null hypothesis is no
longer suitable because we expect to have (and indeed are tasked to find) heterogeneous treatment
effect. Recently, Fogarty [2016] developed a valid studentized test for Neyman’s null hypothesis that
the average treatment effect is equal to zero, (2n)−1
∑
ij Yij(1) − Yij(0) = 0, under Rosenbaum’s
sensitivity model. We briefly describe Fogarty’s test. Let Di denote the treated-minus-control
difference in the ith matched pair, Di = (Ai1−Ai2)(Yi1−Yi2). Fix the sensitivity parameter Γ and
define
Di,Γ = Di −
(
Γ− 1
Γ + 1
)
|Di|, DΓ = 1
n
n∑
i=1
Di,Γ, and se(DΓ)
2 =
1
n(n− 1)
n∑
i=1
(Di,Γ −DΓ)2.
Fogarty [2016] showed that the one-sided student-t test that rejects Neyman’s hypothesis when
DΓ
se(DΓ)
> Φ−1(1− α)
is asymptotically valid with level α under Rosenbaum’s sensitivity model (2) and mild regularity
conditions. This test can be easily extended to test the null that the average treatment effect is no
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greater than δ by replacing Di with Di − δ. Fogarty [2016] also provided a randomization-based
reference distribution in addition to the large-sample normal approximation.
The above test for the average treatment effect can be readily extended to comparing treatment
rules. Recall that equation (1) implies the value difference of two rules r1 and r2 is a weighted
difference of two conditional average treatment effects on the set r1 > r2 and r2 > r1. When the two
rules are nested (without loss of generality assume r2 ≥ r1), testing the null hypothesis that r1 6≺Γ r2
is equivalent to testing a Neyman-type hypothesis E[Y (1)−Y (0)|r2 > r1] ≤ 0 under the Γ-sensitivity
model. We can simply apply Fogarty’s test to the matched pairs (indexed by i) that satisfy
r2(Xi1) > r1(Xi1). When the two rules are not nested, we can flip the sign of Di for those i such
that r2(Xi1) < r1(Xi1) and then apply Fogarty’s test. In summary, to test the null hypothesis that
r1 6≺Γ r2, we can simply apply Fogarty’s test to {Di · [r2(Xi1)− r1(Xi1)], for i such that r1(Xi1) 6=
r2(Xi1)}. To test the hypothesis r1 6≺Γ,δ r2, we can use Fogarty’s test for the average treatment
effect no greater than δ · (n/m) where m = ∣∣{i : r1(Xi1) 6= r2(Xi2)}∣∣.
2.4 Sensitivity value of treatment rule comparison
A hallmark of Rosenbaum’s sensitivity analysis framework is its tipping-point analysis, and that
extends to the comparison of treatment rules. When testing r1 6≺Γ r2 with a series of Γ, there exists
a smallest Γ such that the null hypothesis cannot be rejected, that is, we are no longer confidence
that r1 is dominated by r2 in that Γ-sensitivity model. This tipping point is commonly referred to
as the sensitivity value [Zhao, 2018]. Formally, we define the sensitivity value for r1 ≺ r2 as
Γ∗α(r1 ≺ r2) = inf{Γ ≥ 1 : The hypothesis V (r1) ≥ V (r2) cannot be rejected
at level α under the Γ-sensitivity model}.
Let r0 be the null treatment rule (for example, assigning control to the entire population). The
sensitivity Γ∗α(r0 ≺ r1) is further abbreviated as Γ∗α(r1).
Zhao [2018] studied the asymptotic properties of the sensitivity value when testing Fisher’s
sharp null hypothesis using a class of signed core statistics. Below, we will give the asymptotic
distribution of Γ∗α(r1 ≺ r2) using Fogarty’s test as described in the last section. The result will be
stated in terms of a transformation of the sensitivity value,
κ∗α(r1 ≺ r2) =
Γ∗α(r1 ≺ r2)− 1
Γ∗α(r1 ≺ r2) + 1
.
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Note that Γ∗ = 1 is transformed to κ∗ = 0 and 0 ≤ κ∗ < 1.
Proposition 1. Assume the treatment rules are nested, r1(x) ≤ r2(x), and let I be the set of
indices i where r1(Xi1) < r2(Xi2). Assuming the moments of |Di| exist and E[Di | r1 < r2] > 0,
then
√
|I|
(
κ∗α(r1 ≺ r2)−
E[Di | r1 < r2]
E[|Di| | r1 < r2]
)
d→ N
(
zαµ, σ
2
)
, as |I| → ∞, (3)
where zα is the upper-α quantile of the standard normal distribution and the parameters µ and σ
2
depend on the distribution of Di (the expressions can be found in the Appendix).
The proof of this proposition can be found in the Appendix. When the treatment rules are
not nested, one can simply replace Di with Di[r2(Xi1) − r1(Xi1)] and the condition r1 < r2 with
r1 6= r2 in the proposition statement. The asymptotic distribution of Γ∗α(r1  r2) can be found by
the delta method and we omit further detail.
The asymptotic distribution in (3) is similar to the one obtained in Zhao [2018, Thm. 1]. When
the treatment rules are nested r1 ≤ r2 and |I| → ∞, the sensitivity value converges to a number
that depends on the distribution of Di,
Γ∗α(r1 ≺ r2) p→
E[|Di| | r1 < r2] + E[Di | r1 < r2]
E[|Di| | r1 < r2]− E[Di | r1 < r2] .
The limit on the right hand side is the design sensitivity [Rosenbaum, 2004] of Fogarty’s test for
comparing the treatment rules. As the sample size converge to infinity, the power of Fogarty’s
test converges to 1 at Γ smaller than the design sensitivity and to 0 at Γ larger than the design
sensitivity. The normal distribution in (3) further approximates of the finite-sample behavior of
the sensitivity value and can be used to compute the power of a sensitivity analysis by the fact
that rejecting r1 6≺Γ r2 at level α is equivalent to Γ∗α(r1 ≺Γ r2) ≥ Γ.
3 Selecting and ranking treatment rules
Next we consider the problem of comparing multiple treatment rules with unmeasured confounding.
To this end, we need to define the goal and the statistical error we would like to control. A problem
related to this is the selecting and ordering of multiple subpopulations [Gupta and Panchapakesan,
1979, Gibbons et al., 1999], for example, given K independent measurements Yi ∼ N(µi, 1) where
µi is some characteristic of the i-th subpopulation. When comparing µi, there are many goals
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we can define. In fact, Gibbons et al. [1999, p. 4] gave a list of 7 possible goals for ranking and
selection of subpopulations and considered them in the rest of their book. We believe at least 3
out of their 7 goals have practically meaningful counterparts in comparing treatment rules. Given
K + 1 treatment rules, R = {r0, r1, . . . , rK}, we may ask, in terms of their values,
1. What is the ordering of all the treatment rules?
2. Which treatment rule is the best?
3. Which treatment rule(s) are better than the null/control r0?
In a randomized experiment or an observational study with no unmeasured confounding, it may be
possible to obtain estimates of the value that are jointly asymptotically normal and then directly
use the methods in Gibbons et al. [1999]. However, as discussed in Section 2, this no longer applies
when there is unmeasured confounding because the value function may only be partially identified.
3.1 Defining the inferential goals
When there is unmeasured confounding, the three goals above need to be modified because the
value function only defines a partial order among the treatment rules (Definition 1). We make the
following definitions
Definition 2. In the Γ-sensitivity model, the maximal rules in R are the ones not dominated by
any other rule,
Rmax,Γ = {ri : ri 6≺Γ rj , ∀j}.
The positive rules are the ones which dominate the control and the null rules are the ones which
don’t dominate the control,
Rpos,Γ = {ri : r0 ≺Γ ri}, Rnul,Γ = R \Rpos,Γ.
The maximal set Rmax,Γ and the null set Rnul,Γ are always non-empty (the latter is because
r0 ∈ Rnul,Γ), become larger as Γ increases, and in general become the full set R as Γ→∞.
In the rest of this section, we will consider the following three statistical problems: for some
pre-specified significance level α > 0,
1. Can we give a set of ordered pairs of treatment rules, OˆΓ ⊂ {(ri, rj), i, j = 0, . . . ,K, i 6= j},
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such that the probability that all the orderings are correct is at least 1− α, that is, P(ri ≺Γ
rj , ∀(ri, rj) ∈ OˆΓ) ≥ 1− α?
2. Can we construct a subset of treatment rules, Rˆmax,Γ, such that the probability that it
contains all maximal rules is at least 1− α, that is, P(Rmax,Γ ⊆ Rˆmax,Γ) ≥ 1− α?
3. Can we construct a subset of treatment rules, Rˆpos,Γ, such that the probability that it does
not cover any null rule is at least 1− α, that is, P(Rˆpos,Γ ∩Rnull,Γ =6 ∅) ≥ 1− α?
Next, we will propose strategies to achieve the above statistical goals based on the test of two
treatment rules with unmeasured confounding described in Section 2.3.
3.2 Goal 1: Ordering the treatment rules
To start with, let’s consider the first goal—ordering the treatment rules, as the statistical inference
is more straightforward. It is the same as the multiple testing problem where we would like to
control the family-wise error rate (FWER) for the collection of hypotheses, {Hij : ri 6≺Γ rj , i, j =
0, . . . ,K, i 6= j}. In principle, we can apply any multiple testing procedure that controls the FWER.
A simple example is Bonferroni’s correction for all the K(K − 1) tests.
In sensitivity analysis problems, we can often greatly improve the statistical power by reducing
the number of tests using a planning sample [Heller et al., 2009, Zhao et al., 2018]. This is because
Rosenbaum’s sensitivity analysis considers the worst case scenario and is generally conservative
when Γ > 1. The planning sample can be further used to order the hypotheses so we can sequentially
test them, for example, using a fixed sequence testing procedure [Koch and Gansky, 1996, Westfall
and Krishen, 2001].
There are many possible ways to screen out, order, and then test the hypotheses. Here we
demonstrate one possibility:
Step 1: Split the data into two parts. The first part is used for planning and the second part for
testing.
Step 2: For every pair of treatment rules (ri, rj), use the planning sample to estimate population
parameters in the asymptotic distribution of the sensitivity value (3).
Step 3: Compute the approximate power of testing Hij : ri 6≺Γ rj in the testing sample using (3).
Order the hypotheses by the estimated power, from highest to lowest.
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Step 4: Sequentially test the ordered hypotheses using the testing sample at level α, until one hy-
pothesis is rejected.
Step 5: Output a Hasse diagram of the treatment rules by using all the rejected hypotheses.
A Hasse diagram is an informative graph to represent a partial order (in our case, ≺Γ). In this
diagram, each treatment rule is represented by a vertex and an edge goes upward from rule ri to
rule rj if ri ≺Γ rj and there exists no rk such that ri ≺Γ rk and rk ≺Γ rj .
Due to transitivity of a partial order, an upward path from ri to rj in the Hasse diagram (for
example r0 to r3 in Figure 1, Γ = 1.3) indicates that ri ≺Γ rj , even if we could not directly reject
ri 6≺Γ rj in Step 4. The next proposition shows that the above multiple testing procedure also
controls the FWER for all the apparent and implied orders represented by the Hasse diagram.
Proposition 2. Let OˆΓ ⊂ {(ri, rj), i 6= j} be a random set of ordered treatment rules obtained
using the procedure above or any other multiple testing procedure. Let
OˆΓ,ext = OˆΓ
⋃
{(ri, rj) : ∃ k1, . . . , km such that (ri, rk1), (rk1 , rk2), . . . , (rkm , rj) ∈ OˆΓ}
be the extended set implied from the Hasse diagram. Then FWER with respect to OˆΓ,ext is the
same as FWER with respect to OˆΓ:
P(ri ≺Γ rj , ∀(ri, rj) ∈ OˆΓ) = P(ri ≺Γ rj , ∀(ri, rj) ∈ OˆΓ,ext).
Proof. We show the two events are equivalent. The ⊆ direction is trivial. For ⊇, notice that any
false positive in OˆΓ,ext, say ri ≺Γ rj implies that there is at least one false positive along the path
from ri to rj , that is, there is at least one false positive among ri ≺Γ rk1 , rk1 ≺Γ rk2 , . . . , rkm ≺Γ rj ,
which are all in OˆΓ. Thus, any false positive in OˆΓ,ext implies that there is also at least one false
positive in OˆΓ.
We illustrate the proposed method using the malaria dataset. We first use half of the data to
estimate the population parameters in (3) for each pair of treatment rules (ri, rj). For every value
of Γ, we use (3) to compute the asymptotic power for the test of Hij : ri 6≺Γ rj using the other half
of the data. We then order the hypotheses by the estimated power, from the highest to the lowest.
In the malaria example, when Γ = 1, the order is
H01, H02, H03, H04, H05, H13, H12, H14, H15, H23, . . . .
14
When Γ = 2, the order becomes
H02, H01, H03, H04, H05, H12, H13, H14, H15, H45, . . . .
Finally we follow Steps 4 and 5 above. We obtained Hasse diagrams for a variety of Γ, which are
shown in Figure 1. As a baseline for comparison, Figure 2 shows the Hasse diagrams obtained by a
simple Bonferroni adjustment for all K(K − 1) = 30 hypotheses using all the data. Although only
half of the data is used to test, ordering the hypotheses not only identified all the discoveries that
the Bonferroni procedure identified, but also made one extra discovery when Γ = 1.3, 1.5, 2.5, 3.5,
and 4, and two extra discoveries when Γ = 1, 1.8, 2, and 3.
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Figure 1: Malaria example: Hasse diagrams obtained using sample-splitting and fixed sequence
testing; α = 0.1.
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Figure 2: Malaria example: Hasse diagrams obtained using Bonferroni’s adjustment; α = 0.1.
3.3 Goal 2: Selecting the best rules
Next we consider constructing a set that covers all the maximal rules. Our proposal is based on
the following observation: if the hypothesis ri 6≺Γ rj can be rejected, then ri is unlikely a maximal
rule. More precisely, because ri ∈ Rmax,Γ implies that ri 6≺Γ rj must be true, by the definition of
the type I error of a hypothesis test,
P(ri 6≺Γ rj is rejected | ri ∈ Rmax,Γ) ≤ α.
This suggests that we can derive a set of maximal rules from an estimated set of partial orders:
Rˆmax,Γ = {ri : (ri, rj) 6∈ OˆΓ, ∀j}. (4)
In other words, Rˆmax,Γ contains all the “leaves” in the Hasse diagram of OˆΓ (a leaf in the Hasse
diagram is a vertex who has no edge going upward). For example, in Figure 1, the leaves are
{r3, r4, r5} when Γ = 1.0 and {r2, r3, r4, r5} when Γ = 1.5. Because
{Rmax,Γ 6⊆ Rˆmax,Γ} = {∃ i ∈
Rmax,Γ such that (ri, rj) ∈ OˆΓ for some j
}
, the estimated set of maximal rules satisfies P(Rmax,Γ 6⊆
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Rˆmax,Γ) ≤ α as desired whenever OˆΓ strongly controls the FWER at level α.
Equation (4) suggests that only one hypothesis ri 6≺Γ rj needs to be rejected in order to exclude
ri from Rˆmax,Γ. This means that, when the purpose is to select the maximal rules, we do not need
to test ri 6≺Γ rj if another hypothesis ri 6≺Γ rk for some k 6= j is already rejected. Therefore, we
can modify the procedure of finding ΩˆΓ to further decrease the size of Rˆmax,Γ obtained from (4).
For example, in the five-step procedure demonstrated in Section 3.2, we can further replace Step 3
by:
Step 3’: After ordering the hypotheses in Step 3, remove any hypothesis Hij : ri ≺Γ rj if there is
already a hypothesis Hik appearing before Hij for some k 6= j.
Again we use the malaria example to illustrate the selection of best treatment rules. As an
example, when Γ = 2.0, Step 3’ reduced the original sequence of hypotheses to the following:
H02, H12, H45, H35, H53, H21.
We used the hold-out samples to test the hypotheses sequentially at level α = 0.1 and stopped at
H45. Therefore, a level α = 0.1 confidence set of the set of maximal elements is {r2, r3, r4, r5} when
Γ = 2. Table 1 lists the estimated maximal set Rˆmax,Γ for Γ = 1, 1.3, 1.5, 1.8, 2, and 2.5.
Table 1: Rˆmax,Γ for different choices of Γ.
Γ Rˆmax,Γ Γ Rˆmax,Γ
1.0 {r3, r4, r5} 2.5 {r2, r3, r4, r5}
1.3 {r3, r4, r5} 3.0 {r1, r2, r3, r4, r5}
1.5 {r2, r3, r4, r5} 3.5 {r1, r2, r3, r4, r5}
1.8 {r2, r3, r4, r5} 4.0 {r1, r2, r3, r4, r5}
2.0 {r2, r3, r4, r5} 6.0 {r0, r1, r2, r3, r4, r5}
3.4 Goal 3: Selecting the positive rules
Finally we consider how to select treatment rules that are better than a control rule. This can
also be transformed to a multiple testing problem for the hypotheses H0i : r0 6≺Γ ri, i = 1, . . . ,K.
Let Rˆpos,Γ be the collection of rejected hypotheses following some multiple testing procedure. By
definition of FWER, P(Rˆpos,Γ ∩ Rnul,Γ) ≤ α if the multiple testing procedure strongly controls
FWER at level α. As an example, one can modify the procedure in (3.2) to select the positive rules
by only considering H0i, i = 1, . . . ,K in Step 3.
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In practice, a small increase of the value function, though statistically significant, may not justify
a policy change. In this case, it may be desirable to estimate the positive rules that dominate the
control rule by margin δ, Rpos,Γ,δ = {ri : r0 ≺Γ,δ ri}. To obtain an estimate of Rpos,Γ,δ, one can
further modify the procedure in (3.2) by replacing the hypothesis H0i : r0 6≺Γ ri with the stronger
r0 6≺Γ,δ ri.
Table 2: Estimated positive rules Rˆpos,Γ,δ for different choices of Γ and δ.
Γ = 1 Γ = 1.3 Γ = 1.5 Γ = 1.8
δ = 0 {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5}
δ = 1 {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5}
δ = 2 {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5}
δ = 4 {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5}
δ = 6 {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r2, r3, r4, r5} {r2}
Γ = 2.0 Γ = 2.5 Γ = 3.0
δ = 0 {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5}
δ = 1 {r1, r2, r3, r4, r5} {r1, r2, r3, r4, r5} {r1, r2, r3}
δ = 2 {r1, r2, r3, r4, r5} {r1, r2, r3} {r1, r2}
δ = 4 {r1, r2, r3} ∅ ∅
δ = 6 ∅ ∅ ∅
Γ = 3.5 Γ = 4.0 Γ = 6.0
δ = 0 {r1, r2, r3} {r1, r2} ∅
δ = 1 {r1, r2} {r1} ∅
δ = 2 ∅ ∅ ∅
δ = 4 ∅ ∅ ∅
δ = 6 ∅ ∅ ∅
We construct Rˆpos,Γ,δ with various choices of Γ and δ for the malaria example. In this case,
δ measures the decrease in the number of Plasmodium falciparum parasites per milliliter of blood
samples averaged over the entire study samples. Table 2 gives a summary of the results. As
expected, the estimated set of positive rules becomes smaller as Γ or δ increases. We observe that,
although r1, r2—assigning treatment to those under 7 and 20—are unlikely the optimal rules if
there is no unmeasured confounding (Table 1), they are more robust to unmeasured confounding
than the others, dominating the control rule up till Γ = 4.0 (Table 2).
4 Simulations
We study and report the performance of three methods of selecting the positive rules Rpos,Γ,δ
using numerical simulations in this section. Simulation results for selecting the maximal rules
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are reported in the Supplementary Materials. We constructed 5 or 10 cohorts of data where the
treatment effect is constant within each cohort but different between the cohorts. After matching,
the treated-minus-control difference in each cohort was normally distributed with mean
1. µ = (0.5, 0.25, 0.25, 0.15, 0.05),
2. µ = (0.5, 0.2,−1.0, 0.2, 0.5),
3. µ = (0.5, 0.5, 0.25, 0.25, 0.25, 0.25, 0.15, 0.15, 0.05, 0.05),
4. µ = (0.5, 0.3, 0.2, 0.0,−1.0,−1.0, 0.5, 0.5, 1.0, 1.0).
The size of each cohort was either 100 or 250.
Three methods of selecting positive rules were considered:
1. Bonferroni: The full data is used to test the hypotheses H0i : r0 6≺Γ ri and the Bonferroni
correction is used to adjust for multiple comparisons.
2. Ordering by power: This is the procedure described in Section 3.2 using sample splitting
and fixed sequence testing.
3. Ordering by value function: This is the same as above except that the hypotheses are
ordered by their estimated value at Γ = 1.
For the second and third methods, we used either a half or a quarter of the matched pairs (randomly
chosen) to order the hypotheses. Extra simulation results using different split proportions are
reported in Supplementary Materials. This simulation was replicated 1000 times to report the
power and the error rate of the methods. The power is defined as the average size of the estimated
set of positive rules Rˆpos,Γ and the error rate is 1− P (Rˆpos,Γ ⊆ Rpos,Γ) with nominal level 0.05.
The results of this simulation study are reported in Tables 3 to 6. The error rate is controlled
under the nominal level in most cases and is usually quite conservative. The conservativeness is
not surprising because Rosenbaum’s sensitivity analysis is a worst-case analysis. In terms of power,
the five methods being compared performed very similarly assuming no unmeasured confounding
(Γ = 1). Bonferroni is still competitive at Γ = 1.5, but ordering the hypotheses by (the estimated)
power, though losing some sample for testing, can be much more powerful at larger values of Γ.
For instance, in Table 5 when Γ = 3.0, two power-based methods are more than twice as powerful
as the Bonferroni method. We observe that only using a small planning sample (25%) seems to
19
work well in the simulations. This is not too surprising given our theoretical results. Proposition 1
suggest that only the first two moments of D and |D| are needed to estimate the sensitivity value
asymptotically.
Table 3: Power and error rate (separated by/) of three methods estimating Rpos,Γ. Power is defined
as the size of Rˆpos,Γ and error rate is defined as 1− P (Rˆpos,Γ ⊆ Rpos,Γ). Treatment effect in the 5
cohorts is given by µ = (0.5, 0.25, 0.25, 0.15, 0.05). The true Rpos,Γ is listed below each Γ value.
Cohort size Method
Γ = 1.0 Γ = 1.8 Γ = 2.0 Γ = 2.3 Γ = 3.0
{r1, . . . , r5} {r1, . . . , r4} {r1, r2, r3} {r1, r2} {r1}
250
Bonferroni 5.00 / 0.00 2.54 / 0.01 1.60 / 0.03 0.72 / 0.02 0.11 / 0.00
Value (50%) 5.00 / 0.00 0.51 / 0.07 0.08 / 0.04 0.00 / 0.00 0.00 / 0.00
Power (50%) 5.00 / 0.00 2.30 / 0.07 1.46 / 0.07 0.74 / 0.04 0.20 / 0.00
Value (25%) 5.00 / 0.00 0.73 / 0.07 0.18 / 0.05 0.03 / 0.01 0.00 / 0.00
Power (25%) 5.00 / 0.00 2.64 / 0.07 1.69 / 0.06 0.85 / 0.05 0.21 / 0.00
100
Bonferroni 4.99 / 0.00 1.39 / 0.02 0.75 / 0.02 0.37 / 0.02 0.08 / 0.00
Value (50%) 4.80 / 0.00 0.49 / 0.07 0.16 / 0.04 0.04 / 0.02 0.00 / 0.00
Power (50%) 4.77 / 0.00 1.15 / 0.05 0.75 / 0.05 0.38 / 0.03 0.15 / 0.02
Value (25%) 4.99 / 0.00 0.61 / 0.06 0.24 / 0.03 0.12 / 0.03 0.01 / 0.00
Power (25%) 4.99 / 0.00 1.33 / 0.05 0.80 / 0.05 0.52 / 0.05 0.12 / 0.00
Table 4: Power and error rate (separated by/) of three methods estimating Rpos,Γ. Power is defined
as the size of Rˆpos,Γ and error rate is defined as 1− P (Rˆpos,Γ ⊆ Rpos,Γ). Treatment effect in the 5
cohorts is given by µ = (0.5, 0.2,−1.0, 0.2, 0.5). The true Rpos,Γ is listed below each Γ value.
Cohort size Method
Γ = 1.0 Γ = 1.5 Γ = 2.0 Γ = 2.5 Γ = 3.5
{r1, r2, r4, r5} {r1, r2, r5} {r1, r2} {r1} ∅
250
Bonferroni 3.14 / 0.00 2.36 / 0.00 0.78 / 0.00 0.45 / 0.01 0.01 / 0.01
Value (50%) 3.21 / 0.00 1.78 / 0.00 0.06 / 0.02 0.00 / 0.00 0.00 / 0.00
Power (50%) 3.21 / 0.00 2.03 / 0.00 0.75 / 0.02 0.47 / 0.02 0.07 / 0.07
Value (25%) 3.25 / 0.00 2.21 / 0.00 0.07 / 0.03 0.00 / 0.00 0.00 / 0.00
Power (25%) 3.25 / 0.00 2.35 / 0.00 0.83 / 0.02 0.54 / 0.02 0.07 / 0.07
100
Bonferroni 3.02 / 0.00 1.19 / 0.00 0.37 / 0.00 0.21 / 0.01 0.02 / 0.02
Value (50%) 3.03 / 0.00 0.71 / 0.00 0.04 / 0.02 0.00 / 0.00 0.00 / 0.00
Power (50%) 3.02 / 0.00 0.93 / 0.00 0.43 / 0.01 0.29 / 0.04 0.08 / 0.08
Value (25%) 3.10 / 0.00 1.12 / 0.00 0.04 / 0.02 0.00 / 0.00 0.00 / 0.00
Power (25%) 3.11 / 0.00 1.32 / 0.00 0.42 / 0.01 0.31 / 0.03 0.07 / 0.07
5 Application: The effect of late retirement on senior health
Finally we apply the proposed method to study the potentially heterogeneous effect of retirement
timing on senior health. Many empirical studies have focused on the effect of retirement timing on
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Table 5: Power and error rate (separated by/) of three methods estimating Rpos,Γ. Power is defined
as the size of Rˆpos,Γ and error rate is defined as 1 − P (Rˆpos,Γ ⊆ Rpos,Γ). Treatment effect in the
10 cohorts is given by µ = (0.5, 0.5, 0.25, 0.25, 0.25, 0.25, 0.15, 0.15, 0.05, 0.05). The true Rpos,Γ is
listed below each Γ value.
Cohort size Method
Γ = 1.0 Γ = 1.8 Γ = 2.2 Γ = 3.0 Γ = 3.5
{r1, . . . , r10} {r1, . . . , r9} {r1, . . . , r6} {r1, r2} {r1}
250
Bonferroni 10.00 / 0.00 6.80 / 0.01 2.41 / 0.00 0.20 / 0.00 0.02 / 0.01
Value (50%) 10.00 / 0.00 0.88 / 0.06 0.00 / 0.00 0.00 / 0.00 0.00 / 0.00
Power (50%) 10.00 / 0.00 6.30 / 0.05 2.34 / 0.03 0.44 / 0.02 0.11 / 0.05
Value (25%) 10.00 / 0.00 1.12 / 0.01 0.00 / 0.00 0.00 / 0.00 0.00 / 0.00
Power (25%) 10.00 / 0.00 7.06 / 0.06 2.73 / 0.02 0.42 / 0.02 0.10 / 0.05
100
Bonferroni 9.99 / 0.00 3.97 / 0.01 1.14 / 0.00 0.12 / 0.00 0.03 / 0.02
Value (50%) 9.95 / 0.00 0.76 / 0.05 0.03 / 0.01 0.00 / 0.00 0.00 / 0.00
Power (50%) 9.91 / 0.00 3.18 / 0.04 1.17 / 0.02 0.28 / 0.03 0.10 / 0.05
Value (25%) 9.95 / 0.00 1.06 / 0.04 0.06 / 0.01 0.00 / 0.00 0.00 / 0.00
Power (25%) 9.99 / 0.00 3.93 / 0.04 1.39 / 0.02 0.25 / 0.02 0.09 / 0.05
short-term and long-term health status of the elderly people [Morrow-Howell et al., 2001, Alavinia
and Burdorf, 2008, Bo¨rsch-Supan and Ju¨rges, 2006]. One theory known as the “psychosocial-
materialist” approach suggests that retiring late may have health benefits because work forms a key
part of the identity of the elderly and provides financial, social and psychological resources [Calvo
et al., 2012]. However, the health benefits of late retirement may differ in different subpopulations
[Dave et al., 2008, Westerlund et al., 2009].
We obtained the observational data from the Health and Retirement Study, an ongoing nation-
ally representative survey of more than 30,000 adults who are older than 50 and their spouses in the
United States. HRS is sponsored by the National Institute of Aging; Detailed information on the
HRS and its design can be found in Sonnega et al. [2014]. We use the RAND HRS Longitudinal
File 2014 (V2), an easy-to-use dataset based on the HRS core data that consists of a follow-up
study of 15, 843 elderly people [RAND, 2018].
We defined the treatment as late retirement (retirement after 65 years old and before 70 years
old) and asked how it impacted self-reported health status at the age of 70 (coded by: 5 - extremely
good, 4 - very good, 3 - good, 2 - fair, and 1 - poor). We included individuals who retired before
70 and had complete measurements of the following confounders: year of birth, gender, education
(years), race (white or not), occupation (1: executives and managers, 2: professional specialty, 3:
sales and administration, 4: protection services and armed forces, 5: cleaning, building, food prep,
and personal services, 6: production, construction, and operation), partnered, annual income, and
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Table 6: Power and error rate (separated by/) of three methods estimating Rpos,Γ. Power is defined
as the size of Rˆpos,Γ and error rate is defined as 1 − P (Rˆpos,Γ ⊆ Rpos,Γ). Treatment effect in the
10 cohorts is given by µ = (0.5, 0.3, 0.2, 0.0,−1.0,−1.0, 0.5, 0.5, 1.0, 1.0). The true Rpos,Γ is listed
below each Γ value.
Cohort size Method
Γ = 1.0 Γ = 1.5 Γ = 2.0 Γ = 2.5 Γ = 3.0
{r1, . . . , r4, r9, r10} {r1, . . . , r4} {r1, r2, r3} {r1, r2} {r1}
250
Bonferroni 5.98 / 0.00 3.51/0.00 1.55 / 0.00 0.37 / 0.00 0.07 / 0.00
Value (50%) 5.97 / 0.02 0.10 / 0.02 0.00 / 0.00 0.00 / 0.00 0.00 / 0.00
Power (50%) 6.00 / 0.02 3.43 / 0.02 1.53 / 0.01 0.56 / 0.02 0.21 / 0.01
Value (25%) 6.02 / 0.03 0.23 / 0.04 0.03 / 0.00 0.01 / 0.00 0.00 / 0.00
Power (25%) 6.02 / 0.02 3.67 / 0.04 1.84 / 0.01 0.66 / 0.01 0.22 / 0.01
100
Bonferroni 5.60 / 0.01 2.42 / 0.00 0.68 / 0.00 0.19 / 0.00 0.06 / 0.00
Value (50%) 5.24 / 0.03 0.22 / 0.03 0.04 / 0.00 0.01 / 0.00 0.00 / 0.00
Power (50%) 5.48 / 0.03 2.23 / 0.03 0.86 / 0.02 0.31 / 0.02 0.16 / 0.02
Value (25%) 5.58 / 0.02 0.71 / 0.03 0.16 / 0.00 0.04 / 0.00 0.01 / 0.00
Power (25%) 5.71 / 0.02 2.61 / 0.03 0.98 / 0.01 0.36 / 0.02 0.14 / 0.02
smoking status. This left us with 1934 treated subjects and 4831 controls. Figure 3 plots the
distribution of retirement age in all samples and in the treatment group. The distribution of
retirement age in the treatment group is right skewed, with a spike of people retiring shortly after
65 years old. In the Supplementary Materials, we give a detailed account of data preprocessing and
sample inclusion criteria.
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Figure 3: Distribution of retirement age
Using optimal matching as implemented in the optmatch R package [Hansen and Klopfer,
2006], we form 1858 matched pairs, matching exactly on the year of birth, gender, occupation, and
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Table 7: Covariate balance after matching.
Control Treated std.diff
Year of birth 1936.27 1936.27 0.00
Female 0.53 0.53 0.00
Non-hispanic white 0.77 0.75 -0.04
Education (yrs) 12.52 12.53 0.00
Occupation: cleaning, building, food prep, and personal services 0.10 0.10 0.00
Occupation: executives and managers 0.16 0.16 0.00
Occupation: production construction and operation occupations 0.28 0.28 0.00
Occupation: professional specialty 0.19 0.19 0.00
Occupation: protection services and armed forces 0.02 0.02 0.00
Occupation: sales and admin 0.25 0.25 0.00
Partnered 0.74 0.74 0.00
Smoke ever 0.63 0.59 -0.08
partnered or not, and balance the race, years of education, and smoking status. Table 7 summarizes
the covariate balance after matching. After matching, the treated and control groups are well-
balanced (Table 7): the standardized differences of all covariates are less than 0.1. Additionally,
the propensity score in the treated and control group have good overlap before and after matching
(see the Supplementary Materials).
We considered two potential effect modifiers, namely gender and occupation. More complicated
treatment rules can in principle be considered within our framework, though having more treatment
rules generally reduces the power of multiple testing. We grouped the 6 occupations into 2 broad
categories: white collar jobs (executives and managers and professional specialties) and blue collar
jobs (sales, administration, protection services, personal services, production, construction, and
operation). There were 4 subgroups defined by these two potential effect modifiers: male, white-
collar workers (G1), female, white-collar workers (G2), male, blue-collar workers (G3), and female,
blue-collar workers (G4). Thus, there were a total of 2
4 = 16 different regimes formed out of
these two effect modifiers. We gave decimal as well as binary codings to the 16 groups: r0 (r0000)
assigns control to everyone, r8 (r1000), r4 (r0100), r2 (r0010), r1 (r0001) assign treatment to one of the
4 subgroups, and so forth. We split the matched samples and used 1/4 of them to plan the test
in the other 3/4. Then we followed the procedures proposed in Section 3 to rank and select the
treatment rules.
Figure 4 reports the estimated Hasse diagram at Γ = 1.2; additional results can be found in
the Supplementary Materials. The estimated maximal rules for various choices of Γ and δ are
reported in Table 8 and the estimated positive rules are reported in the Supplementary Materials.
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Figure 4: The effect of late retirement on health: Hasse diagram at Γ = 1.2
According to Table 8, the maximal rules under the no unmeasured confounding assumption are
r11 (r1011) which assigns late retirement to all but female, white-collar workers, r13 (r1101) which
assigns late retirement to all but male, blue-collar workers, and r15 (r1111) which assigns treatment
to everyone. When Γ increases to 1.2, r9 (r1001) which assigns treatment to male, white-collar
workers and female, blue-collar workers, further enters the set of maximal rules. The estimated
positive rules suggest that r9 (r1001) and r1 (r0001) which only assigns late retirement to female blue
collar workers, though not among the maximal rules at Γ = 1 in Table 8, are the most robust to
unmeasured confounding. This suggests that later retirement perhaps benefit female blue-collar
workers more than others.
Table 8: The effect of late retirement on health: Rˆmax,Γ for different choices of Γ.
Γ Rˆmax,Γ
1.0 {r11, r13, r15}
1.2 {r9, r11, r13, r15}
1.35 {r1, r3, r5, r7, r9, r11, r13, r15}
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Does Γ = 1.2 represent a weak or strong unmeasured confounder? Rosenbaum and Silber
[2009] proposed to amplify Γ to a two-dimensional curve indexed by (Λ,∆), where Λ describes the
relationship between the unmeasured confounder and the treatment assignment, and ∆ describes
the relationship between the unmeasured confounder and the outcome. For instance, Γ = 1.2
corresponds to an unmeasured confounder associated with a doubling of the odds of late retirement
and a 75% increase in the odds of better health status at the age of 70 in each matched pair, i.e.,
(∆,Λ) = (2.0, 1.75). Hsu and Small [2013] further proposed to calibrate (Λ,∆) values to coefficients
of observed covariates, however, their method only works for binary outcome and binary treatment.
In the Supplementary Materials, we describe a calibration analysis that handle the ordinal self-
reported health status level in our application that has 5 levels.
We follow Hsu and Small [2013] and use a plot to summarize the calibration analysis. In
Figure 5, the blue curve represents Rosenbaum and Silber [2009]’s two-dimensional amplification
of Γ = 1.2 indexed by (Λ,∆). The estimated coefficients of observed covariates are represented
by black dots (after taking an exponential so they are comparable to (Λ,∆)). We followed the
suggestion in Gelman [2008] and standardized all the non-binary covariates to have mean 0 and
standard deviation 0.5, so the coefficient of each binary variable can be interpreted directly and the
coefficients of each continuous/ordinal variable can be interpreted as the effect of a 2-SD increase in
the covariate value, which roughly corresponds to flipping a binary variable from 0 to 1. Note that all
coefficients are under the Γ = 1.2 curve. In fact, Γ = 1.2 roughly corresponds to a moderately strong
binary unobserved covariate whose effects on late retirement and health status are comparable to
a binary covariate U constructed from smoking and education (red star in Figure 5).
6 Discussion
In this paper we proposed a general framework to compare, select, and rank treatment rules when
there is a limited degree of unmeasured confounding and illustrated the proposed methods by two
real data examples. A central message is that the best treatment rule (with the largest estimated
value) assuming no unmeasured confounding is often not the most robust to unmeasured confound-
ing. This may have important policy implications when individualized treatment rules are learned
from observational data.
Because the value function only defines a partial order on the treatment rules when there is
unmeasured confounding, there is a multitude of statistical questions one can ask about selecting
and ranking the treatment rules. We have considered three questions that we believe are most
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Figure 5: The effect of latent retirement on health: Calibration of the sensitivity analysis. The blue
curve is Rosenbaum and Silber [2009]’s amplification of Γ = 1.2. Black dots represent estimated
coefficient of each observed covariate. Red marker represents the aggregate effect of flipping smoking
status and increasing education by 2 standard deviations.
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relevant to policy research, but there are many other questions (such as in Gibbons et al. [1999])
one could ask.
In principle, our framework can be used with an arbitrary number of prespecified individualized
treatment rules. However, to maintain a good statistical power in the multiple testing, the prespec-
ified treatment rules should not be too many. This limitation makes our method most suitable as
a confirmatory analysis to complement machine learning algorithms for individualized treatment
rule discovery. Alternatively, if the number of decision variables is relatively low due to economic
or practical reasons, our method is also reasonably powered for treatment rule discovery.
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A Appendix: Proof of Proposition 1
To simplify the notation, suppose r1(Xi) < r2(Xi) for all 1 ≤ i ≤ I. Let
Di,Γ = Di −
(
Γ− 1
Γ + 1
)
|Di,Γ|, D = 1
I
I∑
i=1
Di, |D| = 1
I
I∑
i=1
|Di|,
DΓ = (1/I)
I∑
i=1
Di,Γ = D −
(
Γ− 1
Γ + 1
)
|D|,
and
se(DΓ)
2 =
1
I2
I∑
i=1
(Di,Γ −DΓ)2.
When E[Di] > 0, Γ∗(r1, r2) is obtained by solving the equation below in Γ:
DΓ
se(DΓ)
= Φ−1(1− α). (5)
Square both sides of the equation above and plug in the expressions for DΓ and se(DΓ)
2. Let
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κ = (Γ− 1)/(Γ + 1) and zα = Φ−1(1− α). Denote
zα = Φ
−1(1− α), |D| = 1
I
I∑
i=1
|Di|, ,
and
s2D =
1
I
I∑
i=1
(Di −D)2, s2|D| =
1
I
I∑
i=1
(|Di| − |D|)2, sD,|D| =
1
I
I∑
i=1
(Di −D)(|Di| − |D|).
One can show the sensitivity value Γ∗(r1, r2) corresponds to κ∗ that solves the following quadratic
equation: (
|D|2 − 1
I
s2|D|z
2
α
)
κ2 − 2
(
D|D| − 1
I
sD,|D|z2α
)
κ+D
2 − 1
I
s2Dc
2
α = 0.
Specifically, we have
κ∗ =
D|D| − 1I sD,|D|z2α ±
√
∆
|D|2 − 1I s2|D|z2α
, (6)
where ∆ = (D|D| − 1I sD,|D|z2α)2 − (|D|
2 − 1I s2|D|z2α)(D
2 − 1I s2Dc2α).
Note
√
∆ = zα
√
1
I
(
s2|D| ·D
2
+ s2D · |D|
2 − 2D|D|sD,|D|
)
+
1
I2
z2α
(
s2D,|D| − s2|D| · s2D
)
.
Let us denote A = E[D] · E[|D|], B = −zα
√
σ2|D| · E[D]2 + σ2D · E[|D|]2 − 2E[D]E[|D|]σD,|D|, C =
E[|D|]2, R1 =
√
I(D|D| −A), R2 =
√
I(|D|2 − C).
We have
κ∗ =
A+ 1√
I
R1 +
1√
I
B
C + 1√
I
R2
+ op
(
1√
I
)
=
(A+ 1√
I
R1 +
1√
I
B) · (1− 1√
I
R2
C )
C
+ op
(
1√
I
)
.
Scale both sides by
√
I and rearrange the terms, we have
√
I
(
κ∗ − A
C
)
=
B
C
+
1
C
R1 − A
C2
R2 + op(1).
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Moreover, let φ : R2 7→ R2 = (xy, y2):
√
I
 D − E[D]
|D| − E[|D|]
 ∼ N(0,Σ), implies
R1
R2
 = √I
D|D| − E[D] · E[|D|]
|D|2 − E[|D|]2
 ∼ N(0, φ′Σ(φ′)T ),
where Σ =
 Var[D], Cov(D, |D|)
Cov(D, |D|), Var[|D|]
 and φ′ =
E[|D|], E[D]
0, 2E[|D|]
.
Plug in the expressions for A, B, and C and compute the variance-covariance matrix of
(1/C,−A/C2)(R1, R2)T : √
I
(
κ∗ − E[D]
E[|D|]
)
∼ N(zαµ, σ2)
where
µ = −
√
σ2|D| · E[D]2 + σ2D · E[|D|]2 − 2E[D]E[|D|]σD,|D|
E[|D|]2 ,
and
σ2 =
Var[D]E2[|D|]−Var[|D|]E2[D]− 2E[D]E[|D|]Cov(D, |D|) + 2E2[D]Var[|D|]
E4[|D|] .
The Supplementary Materials contain additional appendices about matching in observational
studies and further simulation and real data results.
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